Zhejiang AngLiKang Pharmaceutical CO.,LTD.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 294321630c
Drug names54First applicant · distinct drug namesAcceptance records82First applicant · distinct acceptance numbersUnder-review numbers22First applicant · current under-review listCo-applicant records9Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/12 06:41.
Drug filings
82 acceptance records as first applicant, grouped into 54 source drug names. Source data as of 2026/11/12 06:41.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Fosfomycin Sodium For Injection 3 records · Latest accepted 2026/11/11
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602780 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602779 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602778 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CDE ↗ |
Mometasone Furoate Cream 1 records · Latest accepted 2026/10/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602599 | Generic | 2026/10/22 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Lidocaine and Prilocaine Cream 2 records · Latest accepted 2026/10/21
Supplement · 2
苯磺酸左氨氯地平片 · No verified English name 2 records · Latest accepted 2026/10/12
Supplement · 2
Amoxicillin Capsules 2 records · Latest accepted 2026/08/12
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601976 | Generic | 2026/08/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Pu Luo Ju Tai Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2601975 | Generic | 2026/08/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Pu Luo Ju Tai Pharma Co., Ltd. romanized | CDE ↗ |
甲硝唑凝胶 · No verified English name 1 records · Latest accepted 2026/07/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601379 | Supplement | 2026/07/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Hangzhou Minsheng Pharmaceutical Co., Ltd | CDE ↗ |
Ilaprazole Enteric-coated Tablets 1 records · Latest accepted 2026/05/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601203 | Generic | 2026/05/27 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
厄贝沙坦氨氯地平片(I) · No verified English name 2 records · Latest accepted 2026/04/09
Generic · 2
厄贝沙坦氨氯地平片(III) · No verified English name 2 records · Latest accepted 2026/04/09
Generic · 2
Crisaborole Ointment 1 records · Latest accepted 2026/02/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600268 | Supplement | 2026/02/07 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Telmisartan And Amlodipine Tablets 1 records · Latest accepted 2026/01/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600123 | Supplement | 2026/01/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Jilin Tian Heng Ying Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
替米沙坦氨氯地平片(II) · No verified English name 1 records · Latest accepted 2026/01/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600121 | Supplement | 2026/01/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Jilin Tian Heng Ying Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Fluticasone Propionate Cream 1 records · Latest accepted 2025/12/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504507 | Generic | 2025/12/31 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
依折麦布阿托伐他汀钙片(I) · No verified English name 1 records · Latest accepted 2025/12/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504496 | Generic | 2025/12/31 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Ezetimibe and Atorvastatin Calcium Tablets(II) 2 records · Latest accepted 2025/12/31
Generic · 2
Upadacitinib Sustained-release Tablets 2 records · Latest accepted 2025/12/30
Generic · 2
Fluocinolone Acetonide，Hydroquinone And Tretinoin Cream 1 records · Latest accepted 2025/09/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2500175 | Generic | 2025/09/29 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 3 records · Latest accepted 2025/09/11
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501811 | Supplement | 2025/09/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHS2301134 | Generic | 2023/04/24 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHS2301133 | Generic | 2023/04/23 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
蔗糖羟基氧化铁咀嚼片 · No verified English name 1 records · Latest accepted 2025/07/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502643 | Generic | 2025/07/22 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Mosapride Citrate Tablets 1 records · Latest accepted 2025/06/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502263 | Generic | 2025/06/24 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Acetylcysteine Injection 1 records · Latest accepted 2025/06/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502000 | Generic | 2025/06/06 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Levocarnitine Oral Solution 1 records · Latest accepted 2025/04/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500895 | Supplement | 2025/04/30 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Kai Run Pharma Co., Ltd. romanized | CDE ↗ |
注射用ALK-N001 · No verified English name 1 records · Latest accepted 2025/02/18
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500201 | New drug | 2025/02/18 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Domperidone Tablets 1 records · Latest accepted 2025/02/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550104 | Supplement | 2025/02/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Sitagliptin and Metformin Hydrochloride Extended-release Tablets 2 records · Latest accepted 2025/02/07
Supplement · 1Generic · 1
Etoricoxib Tablets 3 records · Latest accepted 2025/01/09
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500179 | Generic | 2025/01/09 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHS2500178 | Generic | 2025/01/09 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHS2500175 | Generic | 2025/01/09 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
洛索洛芬钠凝胶膏 · No verified English name 1 records · Latest accepted 2025/01/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500120 | Generic | 2025/01/08 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Trimebutine Maleate Tablets 2 records · Latest accepted 2024/12/28
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404603 | Generic | 2024/12/28 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2404602 | Generic | 2024/12/28 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Lanthanum Carbonate Chewable Tablets 1 records · Latest accepted 2024/12/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402190 | Supplement | 2024/12/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Cefalexin Capsules 4 records · Latest accepted 2024/12/06
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402077 | Supplement | 2024/12/06 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHB2402076 | Supplement | 2024/12/06 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHB2350627 | Supplement | 2023/08/18 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHB2301830 | Supplement | 2023/08/17 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Fluvastatin Sodium Extended Release Tablets 1 records · Latest accepted 2024/12/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404228 | Generic | 2024/12/06 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2024/11/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404053 | Generic | 2024/11/26 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Thioctic Acid Injection 2 records · Latest accepted 2024/11/12
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403866 | Generic | 2024/11/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2403865 | Generic | 2024/11/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Doxofylline Tablets 2 records · Latest accepted 2024/10/25
Supplement · 2
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2024/08/14
Generic · 2
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2024/08/09
Generic · 2
Diclofenac Sodium Enteric-coated Tablets 1 records · Latest accepted 2024/07/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402146 | Generic | 2024/07/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Metformin Hydrochloride And Empagliflozin Extended Release Tablets 1 records · Latest accepted 2024/06/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401866 | Generic | 2024/06/22 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
腺苷钴胺胶囊 · No verified English name 1 records · Latest accepted 2024/06/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401689 | Generic | 2024/06/05 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Sevelamer Carbonate Tablets 1 records · Latest accepted 2024/06/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401665 | Generic | 2024/06/04 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
头孢克肟颗粒 · No verified English name 1 records · Latest accepted 2024/04/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401322 | Generic | 2024/04/30 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Levofloxacin Tablets 1 records · Latest accepted 2024/04/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401067 | Generic | 2024/04/10 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Methocarbamol Injection 2 records · Latest accepted 2024/04/03
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401003 | Generic | 2024/04/03 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2400714 | Generic | 2024/02/29 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Levocarnitine Injection 1 records · Latest accepted 2023/12/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303573 | Generic | 2023/12/22 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Innovation Bio Co., Ltd. romanized | CDE ↗ |
Amlodipine Besylate Tablets 2 records · Latest accepted 2023/12/22
Generic · 2
Doxofylline Injection 1 records · Latest accepted 2023/12/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303331 | Generic | 2023/12/01 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Innovation Bio Co., Ltd. romanized | CDE ↗ |
Pregabalin Capsules 2 records · Latest accepted 2023/08/16
Generic · 2
Prucalopride Succinate Tablets 2 records · Latest accepted 2023/03/04
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300464 | Supplement | 2023/03/04 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2300463 | Supplement | 2023/03/04 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Polycarbophil Calcium Tablets 1 records · Latest accepted 2023/01/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300253 | Generic | 2023/01/31 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Sitagliptin Phosphate Tablets 3 records · Latest accepted 2022/11/18
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202014 | Generic | 2022/11/18 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHS2202013 | Generic | 2022/11/18 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| CYHS2202012 | Generic | 2022/11/18 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
头孢拉定胶囊 · No verified English name 1 records · Latest accepted 2022/04/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250199 | Supplement | 2022/04/06 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Compound α-Ketoacid Tablets 1 records · Latest accepted 2021/09/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101780 | Generic | 2021/09/26 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Hydrotalcite Chewable Tablets 1 records · Latest accepted 2021/08/19
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150808 | Supplement | 2021/08/19 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
头孢克肟胶囊 · No verified English name 1 records · Latest accepted 2021/05/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150604 | Supplement | 2021/05/18 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
Changes in the last 90 days
7 events from 2026/08/15 to 2026/11/12. CDE data as of 2026/11/12 06:41; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 7 applications
- 2026/11/11Accepted
Fosfomycin Sodium For Injection
CYHS2602780
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ - 2026/11/11Accepted
Fosfomycin Sodium For Injection
CYHS2602779
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ - 2026/11/11Accepted
Fosfomycin Sodium For Injection
CYHS2602778
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ - 2026/10/22Accepted
Mometasone Furoate Cream
CYHS2602599
Fact date: 2026/10/22 · Site observation date: 2026/10/23
View source ↗ - 2026/10/21Accepted
Lidocaine and Prilocaine Cream
CYHB2601917
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/12Accepted
苯磺酸左氨氯地平片 · No verified English name
CYHB2601869
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ - 2026/10/12Accepted
苯磺酸左氨氯地平片 · No verified English name
CYHB2601868
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗
Under review
22 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Fosfomycin Sodium For Injection | CYHS2602780 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CDE ↗ |
| Fosfomycin Sodium For Injection | CYHS2602779 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CDE ↗ |
| Fosfomycin Sodium For Injection | CYHS2602778 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhe Bei Pharma Co., Ltd. romanized | CDE ↗ |
| Mometasone Furoate Cream | CYHS2602599 | Generic | 2026/10/22 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Lidocaine and Prilocaine Cream | CYHB2601917 | Supplement | 2026/10/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | CYHB2601869 | Supplement | 2026/10/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | CYHB2601868 | Supplement | 2026/10/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Amoxicillin Capsules | CYHS2601976 | Generic | 2026/08/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Pu Luo Ju Tai Pharma Co., Ltd. romanized | CDE ↗ |
| Amoxicillin Capsules | CYHS2601975 | Generic | 2026/08/12 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Pu Luo Ju Tai Pharma Co., Ltd. romanized | CDE ↗ |
| 甲硝唑凝胶 · No verified English name | CYHB2601379 | Supplement | 2026/07/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Hangzhou Minsheng Pharmaceutical Co., Ltd | CDE ↗ |
| Ilaprazole Enteric-coated Tablets | CYHS2601203 | Generic | 2026/05/27 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| 厄贝沙坦氨氯地平片(III) · No verified English name | CYHS2600814 | Generic | 2026/04/09 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| 厄贝沙坦氨氯地平片(I) · No verified English name | CYHS2600813 | Generic | 2026/04/09 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Telmisartan And Amlodipine Tablets | CYHB2600123 | Supplement | 2026/01/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Jilin Tian Heng Ying Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| 替米沙坦氨氯地平片(II) · No verified English name | CYHB2600121 | Supplement | 2026/01/21 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Jilin Tian Heng Ying Rui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Fluticasone Propionate Cream | CYHS2504507 | Generic | 2025/12/31 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| 依折麦布阿托伐他汀钙片(I) · No verified English name | CYHS2504496 | Generic | 2025/12/31 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Ezetimibe and Atorvastatin Calcium Tablets(II) | CYHS2504495 | Generic | 2025/12/31 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Upadacitinib Sustained-release Tablets | CYHS2504480 | Generic | 2025/12/30 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Mosapride Citrate Tablets | CYHS2502263 | Generic | 2025/06/24 | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Trimebutine Maleate Tablets | CYHS2404603 | Generic | 2024/12/28 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Trimebutine Maleate Tablets | CYHS2404602 | Generic | 2024/12/28 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
40 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/12 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Etoricoxib Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20264640 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20264639 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20264641 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvastatin Sodium Extended Release Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20264495 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rosuvastatin Calcium and Ezetimibe Tablets (I) | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20264317 | 2026/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20263918 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20263919 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 头孢克肟颗粒 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20263543 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sevelamer Carbonate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20263512 | 2026/03/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Domperidone Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20093779 | 2026/02/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Diclofenac Sodium Enteric-coated Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20256225 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258280 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 恩格列净二甲双胍缓释片(II) · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20256037 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxofylline Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20000011 | 2025/11/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Doxofylline Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258247 | 2025/11/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255669 | 2025/10/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255630 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255631 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin and Metformin Hydrochloride Extended-release Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255065 | 2025/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methocarbamol Injection | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20254988 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amlodipine Besylate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20254697 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amlodipine Besylate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20254696 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxofylline Injection | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang Innovation Bio Co., Ltd. romanized | 国药准字H20253360 | 2025/02/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pregabalin Capsules | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253180 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pregabalin Capsules | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253179 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Polycarbophil Calcium Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244500 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefalexin Capsules | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H33020266 | 2024/07/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefalexin Capsules | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20247154 | 2024/07/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244371 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244113 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244112 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244114 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Compound α-Ketoacid Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20233753 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 头孢拉定胶囊 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H33020270 | 2023/03/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Hydrotalcite Chewable Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20064289 | 2022/09/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢克肟胶囊 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20070101 | 2022/05/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ticagrelor Tablets | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20223100 | 2022/03/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20083459 | 2021/12/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20083460 | 2021/12/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢克洛缓释片 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20020456 | 2020/07/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
28 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/12 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸阿替卡因 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20250001435 | I | 2025/12/30 | CDE ↗ |
| 氨苄西林 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20250000016 | A | 2026/06/01 | CDE ↗ |
| 阿莫西林 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20240001559 | A | 2026/06/01 | CDE ↗ |
| 枸橼酸莫沙必利 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20240001129 | A | 2026/08/21 | CDE ↗ |
| 布比卡因 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20230001273 | A | 2025/11/14 | CDE ↗ |
| 头孢拉定 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20230001044 | A | 2025/07/09 | CDE ↗ |
| 多潘立酮 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20230000585 | A | 2025/04/28 | CDE ↗ |
| 碳酸镧 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20220001024 | A | 2024/06/28 | CDE ↗ |
| 头孢泊肟酯 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190008302 | A | 2024/02/05 | CDE ↗ |
| 盐酸班布特罗 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007464 | A | 2024/02/05 | CDE ↗ |
| 维生素E烟酸酯 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007463 | A | 2024/02/05 | CDE ↗ |
| 左氧氟沙星 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007461 | A | 2024/02/05 | CDE ↗ |
| 西沙必利 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007459 | A | 2024/02/05 | CDE ↗ |
| 头孢克肟 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007458 | A | 2024/02/05 | CDE ↗ |
| 苯磺酸左氨氯地平 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007326 | A | 2023/10/08 | CDE ↗ |
| 头孢氨苄 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007325 | A | 2026/10/14 | CDE ↗ |
| 头孢克洛 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007323 | A | 2023/10/08 | CDE ↗ |
| 谷维素 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007319 | A | 2023/05/19 | CDE ↗ |
| 多索茶碱 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007315 | A | 2023/10/08 | CDE ↗ |
| 糠甾醇 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007314 | A | 2023/05/19 | CDE ↗ |
| 头孢拉定 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007309 | A | 2026/06/17 | CDE ↗ |
| 头孢羟氨苄 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007306 | A | 2025/06/26 | CDE ↗ |
| 替米沙坦 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190006462 | A | 2024/02/08 | CDE ↗ |
| 硫酸头孢匹罗 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190004239 | A | — | CDE ↗ |
| 托西酸舒他西林 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190002241 | A | — | CDE ↗ |
| 头孢他啶/L-精氨酸 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20170002145 | A | 2024/10/10 | CDE ↗ |
| 头孢拉定 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20170002142 | A | 2024/10/10 | CDE ↗ |
| 头孢他啶 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20170002067 | A | 2024/10/16 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
9 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/12 06:41.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Sacubitril Valsartan Sodium Tablets | CYHS2502355 | Generic | 2025/07/03 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2502354 | Generic | 2025/07/03 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| 布比卡因脂质体注射液 · No verified English name | CYHS2501973 | Generic | 2025/06/03 | Zhejiang Hai Chang Biopharmaceuticals Technology Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Domperidone Tablets | CYHS2402862 | Generic | 2024/08/31 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | CYHB2400739 | Supplement | 2024/05/31 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | CYHB2400738 | Supplement | 2024/05/31 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | CYHS2303514 | Generic | 2023/12/19 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Compound α-Ketoacid Tablets | CYHS2303205 | Generic | 2023/11/22 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
| Lanthanum Carbonate Chewable Tablets | CYHS2300628 | Generic | 2023/02/24 | Wen Zhou Hai He Pharma Co., Ltd. romanized; Zhejiang AngLiKang Pharmaceutical CO.,LTD. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/12 06:41
- Chemical-drug catalogue
- Last successful update: 2026/11/12 06:38
- Full API register
- Last successful update: 2026/11/12 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.